Yeast Infection Market Projected to Witness Vigorous Expansion of 5.2% by 2023

Market Research Future adds new report of “Yeast Infection Market Research Report- Global Forecast till 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players in yeast infection market are

• Scynexis (US)
• Synmedic Laboratories (India)
• Merck & Co., Inc. (US)
• Astellas (Japan)
• Bayer AG (Germany)
• Mentis Pharma Ltd. (India)
• Abbott (US)
• Novartis AG (Switzerland)
• Pfizer Inc. (US)
• Sanofi (France)
• ALLERGAN (Ireland)
• AstraZeneca (UK)

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/4228

Market Segments:

The global yeast infection market is segmented on the basis of pathogen, types, treatment, and end users.

• On the basis of Pathogens, the market is segmented into Candida albicans, Candida glabrata, Candida rugosa

• On the basis of Types, the market is categorized into vaginal yeast infection, skin yeast infection, throat yeast infection

• On the basis of Treatment, the market is segmented into drug treatment and surgery. Drug treatment is further classified into cream, ointment, tablet, and suppository

• On the basis of End Users, the market is segmented into hospital, clinics, ambulatory centers

Market Highlight:

Yeast infection is also known as candidiasis. Candidiasis is an infection caused by numerous types of yeast called Candida. The most common type of yeast causing infection is Candida albicans. This yeast is normally present on the skin, in the intestines and vagina, but under normal conditions it doesn’t cause infection. However, sometimes it can develop into an infection of the mouth, vagina or skin due to weak immune response, unhygienic conditions, and other factors.

Yeast infection can occur due to many reasons such as weak immunity, unhygienic conditions, and presence of a conducive environment for the growth of the associated microbes. In addition to infants, people suffering from diabetes, obesity, hypothyroidism, inflammatory disorders are also prone to catching yeast infection. The global yeast infection market is majorly driven by increasing prevalence of autoimmune diseases, continuously increasing geriatric population, and increasing number of patients suffering from HIV. According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), by the end of 2015, approximately 36.7 million people worldwide were suffering from HIV/AIDS , out of which 1.8 million were children below 15 years. Moreover, rising demand for antifungal drugs and government support for research & development have fuelled the market growth. However, side effects of the treatment may hinder the growth of the market.

The global yeast infection market is expected to grow at a CAGR of 5.2% during the forecasted period.

Intended Audience

• Pharmaceutical manufacturers and suppliers
• Medical research laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Potential Investors

Browse Report Details @ https://www.marketresearchfuture.com/reports/yeast-infection-market-4228

Regional Analysis:

The Americas account for the largest share in the global yeast infection market owing to presence of huge geriatric population and increasing number of patients suffering from immune diseases. According to the Autoimmune Registry, in 2012, approximately 14.7 million Americans were suffering from auto immune diseases.

Europe is the second largest market and holds a noticeable share in the global yeast infection market. The European market is expected to grow significantly during the forecast period owing to availability of advanced treatment facilities, skilled medical professionals, and government support for research & development.

Increasing prevalence of HIV in Asia Pacific region is the crucial factor for the market growth. Rising awareness about the infections and availability of new treatment methods drive the market in this region. In Asia Pacific, the market shows growth opportunities in China and India.

However, the Middle East & Africa is expected to show the least growth in this market due to some major factors such as lack of awareness about the yeast infections, limited access and availability of treatment facilities.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.